Gene therapy could improve genetic deafness
The study represents the first time the injectable gene therapy has been evaluated in teenagers and adults.
List view / Grid view
The study represents the first time the injectable gene therapy has been evaluated in teenagers and adults.
Eli Lilly and Company’s $610 million acquisition of Akouos will fast-track gene therapies that restore, improve and preserve hearing for patients worldwide.
Analysing the components of gentamicin, researchers have developed a new formulation for the antibiotic that does not cause deafness.